Prof. Walter H. Gunzburg has been a Professor of Virology since 1996 and is an internationally respected scientist. He has had over 30 years of experience in biotech. He received his Ph.D. in the UK in 1984 and held a postdoctoral position at the Ludwig Institute in Berne (1984-1986), as well as group leader positions at the Medical College of Georgia, USA (1986-1988), and at the GSF (now Helmholz) in Munich, where he also habilitated at the University of Munich. He has been a key scientific advisor to the international vaccine company Bavarian Nordic from 1994 to 2001, and was involved in their successful IPO. After this, he was the founder and Director of the Christian Doppler Laboratory for Gene Therapeutic Vectors. Currently, he is a board member of ViruSure, a virus and prion testing company located in Vienna that he also cofounded and that was recently acquired by Asahi Kasei.
Prof. Walter H. Gunzburg has been a Professor of Virology since 1996 and is an internationally respected scientist. He has had over 30 years of experience in biotech. He received his Ph.D. in the UK in 1984 and held a postdoctoral position at the Ludwig Institute in Berne (1984-1986), as well as group leader positions at the Medical College of Georgia, USA (1986-1988), and at the GSF (now Helmholz) in Munich, where he also habilitated at the University of Munich. He has been a key scientific advisor to the international vaccine company Bavarian Nordic from 1994 to 2001, and was involved in their successful IPO. After this, he was the founder and Director of the Christian Doppler Laboratory for Gene Therapeutic Vectors. Currently, he is a board member of ViruSure, a virus and prion testing company located in Vienna that he also cofounded and that was recently acquired by Asahi Kasei.